Peter L. Choyke MD, FACRChief, Molecular Imaging Branch, National Cancer Institute; Senior Investigator, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
Dr. Peter Choyke is a diagnostic radiologist at the National Cancer Institute with a long-standing focus on the imaging of genitourinary malignancies, particularly prostate cancer. He completed a residency at Yale and fellowship at Penn before joining the faculty at Georgetown University. In 1988, he moved to the NIH, where he is now the Chief of the Molecular Imaging Branch in the National Cancer Institute.
Dr. Choyke is an inventor, along with Brad Wood, MD and Peter Pinto, MD, on a US government patent for MRI-Ultrasound fusion biopsy of the prostate which was licensed to Philips Medical Systems and became the product known as UroNav.
Recent Contributions to PracticeUpdate:
- Optimizing Combined MRI-Targeted and Systematic Biopsy Strategies
- Influence of 5-ARIs on Prostate Cancer Detection With MRI
- 18F-Fluciclovine PET/CT vs Conventional Imaging Alone to Guide Postprostatectomy Salvage Radiotherapy
- Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impacts Clinical Outcomes
- Computer-Aided Diagnosis of Prostate Cancer on MRI Using a Convolutional Neural Network Algorithm